— Fundamental Stock Analysis and Report Card
Located in St. Louis, MO, US. Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
Revenue, earnings and profitability.
Strong revenue growth and earnings can attract investors, driving the stock price up. Profitability indicates the company's efficiency and sustainability, which impacts investor confidence. Poor performance in these areas can lead to a decrease in stock price.
Revenue History
Earnings History
Margins
Income & Cash Flow analysis.
An income statement shows what a company earned and spent over a period — revenue at the top, costs and expenses in between, and net income at the bottom. A cash flow statement tracks the actual cash moving in and out, across operations, investing, and financing. Read together, they show whether reported earnings are backed by real cash.
Q1 2026 Total ($) | Q1 2026 Margin (%) | |
|---|---|---|
| Revenue | 49.9b +3.3b +7.1% | |
| Gross Income | 10.9b +5.7b +110.3% | 22% +10.7pp +96.3% |
| EBITDA | 2.6b +332.0m +14.9% | 5% +0.3pp +7.2% |
| Operating Income | 1.9b +327.0m +21.3% | 4% +0.4pp +13.2% |
| Net Income | 1.5b +230.0m +17.5% | 3% +0.3pp +9.7% |
| Earnings Per Share | 3.13 +0.5 +18.6% | |
| Operating Cash Flow | 3.6b +2.1b +138.4% | 7% +4.0pp +122.5% |
| Free Cash Flow | 3.4b +2.0b +147.3% | 7% +3.9pp +130.8% |
| Research & Development | n/a n/a n/a | n/a n/a n/a |